15.01.2015 Views

CST Guide:

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

24<br />

Section III: Workflow Tools<br />

Screening & Quantification<br />

using ELISA to screen and quantify<br />

cellular responses at the target level<br />

How can I quantify levels of total and post-translationally<br />

modified proteins in response to cell stimuli<br />

The sandwich enzyme-linked immunosorbent assay (ELISA) is a quantitative, microplate-based assay<br />

that detects changes in abundance of a target protein within a cell sample using a capture antibody<br />

coated to the plate and a detection antibody to generate signal. Unlike a western blot that achieves<br />

specificity by using a single antibody combined with separation of protein by size, an ELISA is highly<br />

specific because it uses two antibodies recognizing different epitopes of the same protein. ELISAs are<br />

broadly utilized in both research and clinical settings; here, we focus on their application in research for<br />

the study of intracellular signaling using phospho-specific and total protein antibodies. ELISAs can also<br />

be used to quantify epigenetic changes using histone acetylation- or methylation-specific antibodies.<br />

The quantitative nature, high sensitivity, plate-based format, and ease-of-use make ELISAs a commonly<br />

used tool for screening in drug discovery and development.<br />

Sandwich ELISAs can be used to:<br />

• Screen therapeutic compounds for effects on post-translational modification of target proteins<br />

• Measure relative changes in total or post-translationally modified protein levels in response<br />

to an external stimuli such as a therapeutic compound<br />

• Assess effects of a cell stimulus at multiple time points or dosages<br />

• Quantitatively measure activation of signaling proteins in a high throughput format<br />

• Confirm data generated by western blot or other antibody-based applications<br />

For example, the PathScan ® Phospho-Bcl-2 (Ser70) Sandwich ELISA Kit from Cell Signaling Technology<br />

(<strong>CST</strong>) was used to assess phosphorylation of Bcl-2 at Ser70 in Jurkat cells treated with a single dose<br />

of paclitaxel. As shown in the figure, paclitaxel treatment increases phosphorylation of Bcl-2 at Ser70<br />

more than 2-fold relative to untreated control without affecting the level of total Bcl-2 protein. The<br />

changes quantified by ELISA were independently observed by western blot.<br />

Assessing the effects of growth factor or cytokine stimulation using ELISA<br />

PathScan ® Phospho-Akt (Thr308) Chemiluminescent<br />

Sandwich ELISA Kit #7135: Relationship between protein<br />

concentration of lysates from untreated and PDGF-treated<br />

NIH/3T3 cells and immediate light generation with chemiluminescent<br />

substrate is shown. Cells (80% confluence)<br />

were treated with PDGF #9909 (50 ng/ml) and lysed after<br />

incubation at 37ºC for 5 min. Graph inset corresponding to<br />

the shaded area shows high sensitivity and a linear response<br />

at the low protein concentration range.<br />

PDGF-treated<br />

Untreated<br />

RLU (x10 5 )<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

0.0<br />

PathScan ® Phospho-Stat3 (Tyr705) Sandwich ELISA Kit #7300: Treatment<br />

of HeLa cells with IFN-α stimulates phosphorylation of Stat3 at Tyr705, detected<br />

by #7300, but does not affect the level of total Stat3 protein, detected by a Stat3<br />

antibody via western analysis. OD 450 readings are shown in the top figure, while<br />

the corresponding western blot using Phospho-Stat3 (Tyr705) (3E2) Monoclonal<br />

Antibody #9138 or Stat3 antibody, is shown in the figure to the right.<br />

Untreated<br />

IFN-α-treated<br />

70<br />

0.1<br />

0.2 0.3 0.4 0.5 0.6<br />

Protein conc. of lysate (mg/ml)<br />

Absorbance 450nm<br />

4<br />

3<br />

2<br />

1<br />

0<br />

14<br />

10<br />

6<br />

2<br />

Phospho-Stat3<br />

(Tyr705)<br />

chapter 24: screening & Quantification<br />

0.02 0.06 0.1<br />

0.7 0.8<br />

Phospho-<br />

Stat3<br />

(Tyr705)<br />

Stat3<br />

– + IFN-α<br />

How PathScan ® Sandwich ELISA Kits can benefit your research:<br />

• Highly Sensitive: detect low abundance target proteins and generate measurable linear<br />

responses at low lysate concentrations<br />

• Rigorously Validated Antibody Pairs: generate accurate data and minimize background,<br />

ensuring reliable results<br />

• Multiple Detection Options: colorimetric or chemiluminescent detection options are available<br />

• Specialized Packaging: bulk orders and custom 384-plate size are available<br />

Paclitaxel treatment of Jurkat cells results<br />

in phosphorylation of Bcl-2 at Ser70.<br />

High sensitivity ELISAs produce a broad dose response<br />

and are linear in low concentration ranges.<br />

PathScan ® Phospho-Bcl-2 (Ser70) Sandwich ELISA Kit #11874:<br />

Treatment of Jurkat cells with Paclitaxel stimulates phosphorylation of Bcl-2<br />

at Ser70, as detected by #11874, but does not affect the levels of total Bcl-2<br />

detected by PathScan ® Total Bcl-2 Sandwich ELISA Kit #12030. Jurkat cells<br />

were untreated or treated with λ phosphatase or Paclitaxel #9807 (1 mM,<br />

20 hr, 37°C). The absorbance readings at 450 nm are shown in the top<br />

figure, while the corresponding western blots using Phospho-Bcl-2 (Ser70)<br />

(5H2) Rabbit mAb #2827 (left panel) or Bcl-2 (D55G8) Rabbit mAb (Human<br />

Specific) #4223 (right panel) are shown in the bottom figure.<br />

λ phosphatase-treated<br />

Untreated<br />

Paclitaxel-treated<br />

Absorbance 450nm<br />

4<br />

3<br />

2<br />

1<br />

0<br />

Phospho-Bcl-2<br />

(Ser70)<br />

Total Bcl-2<br />

PathScan ® Phospho-EGF Receptor (Tyr1068) Sandwich ELISA<br />

Kit #7240: The relationship between protein concentration of lysates<br />

from untreated and EGF-treated A-431 cells and kit assay optical<br />

density readings. After starvation, A-431 cells (85% confluence) were<br />

treated with EGF #8916 (100 ng/ml, 5 min, 37°C) and then lysed.<br />

EGF-treated<br />

Control<br />

2.5<br />

1.5<br />

1.0<br />

0.5<br />

Absorbance 450nm 2.0<br />

0<br />

0.05 0.10 0.15 0.20 0.25<br />

Protein conc. of lysate (mg/ml)<br />

0.30<br />

– – +<br />

+ – –<br />

– – +<br />

+ – –<br />

Paclitaxel<br />

λ Phosphatase<br />

In a second example, the PathScan ® Phospho-Akt (Thr308) Chemiluminescent Sandwich ELISA Kit<br />

#7135 was used to examine the effects growth factor stimulation on phosphorylation of Akt at Thr308,<br />

an indicator of Akt activation and signaling. As shown in the figure, PDGF-mediated activation of Akt<br />

was quantified along a range of lysate levels, demonstrating the kit’s high sensitivity and a linear<br />

response at low protein concentrations. A similar assessment of the effects of cytokine stimulation on<br />

phosphorylation of Stat3 at Tyr705 was performed using #7300.<br />

272 For Research Use Only. Not For Use in Diagnostic Procedures. See pages 302 & 303 for Pathway Diagrams, Application, and Reactivity keys.<br />

<strong>CST</strong> Technical Support<br />

When you contact <strong>CST</strong> for technical support, you can be confident you will be working with a colleague you can trust,<br />

striving to provide the highest quality products and services to you, our customer. Please see our Technical Support<br />

resource page online for contact information. www.cellsignal.com/cstsupport<br />

www.cellsignal.com/screening<br />

273

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!